These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 34669777)

  • 1. Estimated prevalence of COVID-19 in Brazil with probabilistic bias correction.
    Figueiredo EA; Polli DA; Andrade BB
    Cad Saude Publica; 2021; 37(9):e00290120. PubMed ID: 34669777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust trend estimation for COVID-19 in Brazil.
    Valente F; Laurini MP
    Spat Spatiotemporal Epidemiol; 2021 Nov; 39():100455. PubMed ID: 34774261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent class analysis of COVID-19 symptoms in Brazil: results of the PNAD-COVID19 survey.
    Moreira RDS
    Cad Saude Publica; 2021; 37(1):e00238420. PubMed ID: 33566990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of current and past COVID-19 in Ohio adults.
    Turner AN; Kline D; Norris A; Phillips WG; Root E; Wakefield J; Li Z; Lemeshow S; Spahnie M; Luff A; Chu Y; Francis MK; Gallo M; Chakraborty P; Lindstrom M; Lozanski G; Miller W; Clark S
    Ann Epidemiol; 2022 Mar; 67():50-60. PubMed ID: 34921991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of Brazilians aged 50 and over that received a doctor's diagnosis of COVID-19: the ELSI-COVID-19 initiative.
    Macinko J; Seixas BV; Woolley NO; Andrade FB; Lima-Costa MF
    Cad Saude Publica; 2020; 36Suppl 3(Suppl 3):e00190320. PubMed ID: 33206833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
    Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
    Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal spread and evolution of SARS-CoV-2 in the second pandemic wave in Brazil.
    Wolf JM; Kipper D; Borges GR; Streck AF; Lunge VR
    J Med Virol; 2022 Mar; 94(3):926-936. PubMed ID: 34596904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obtaining Prevalence Estimates of Coronavirus Disease 2019: A Model to Inform Decision-Making.
    Sahlu I; Whittaker AB
    Am J Epidemiol; 2021 Aug; 190(8):1681-1688. PubMed ID: 33831172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating COVID-19 Hospitalizations in the United States With Surveillance Data Using a Bayesian Hierarchical Model: Modeling Study.
    Couture A; Iuliano AD; Chang HH; Patel NN; Gilmer M; Steele M; Havers FP; Whitaker M; Reed C
    JMIR Public Health Surveill; 2022 Jun; 8(6):e34296. PubMed ID: 35452402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.
    Martinez EZ; Passos ADC; Fabbro ALD; Silva ASD; Escarso AC; Pazin-Filho A; Fonseca BALD; Maciel BC; Araújo DCAE; Clé DV; Gaspar GG; Santos JLFD; Ferreira JBB; Souza JP; Mello LM; Santos LLD; Passos LMR; Siconelli MJL; Cavalli RC; Santana RC; Calado RDT; Scarpelini S; Bollela VR; Floriano VG; Bellissimo-Rodrigues F
    Rev Soc Bras Med Trop; 2021; 54():e02102021. PubMed ID: 34231775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A forensic analysis of SARS-CoV-2 cases and COVID-19 mortality misreporting in the Brazilian population.
    Galvêas D; Barros F; Fuzo CA
    Public Health; 2021 Jul; 196():114-116. PubMed ID: 34182256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
    Lim T; Delorey M; Bestul N; Johannson MA; Reed C; Hall AJ; Fry AM; Edens C; Semenova V; Li H; Browning P; Desai R; Epperson M; Jia T; Thornburg NJ; Schiffer J; Havers FP
    Clin Infect Dis; 2021 Nov; 73(10):1831-1839. PubMed ID: 33639620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting COVID-19 Seroprevalence Survey Results to Account for Test Sensitivity and Specificity.
    Meyer MJ; Yan S; Schlageter S; Kraemer JD; Rosenberg ES; Stoto MA
    Am J Epidemiol; 2022 Mar; 191(4):681-688. PubMed ID: 34791024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic inequalities in the incidence of COVID-19 in National Household Sample Survey cohort, Brazil, 2020.
    Aguiar IWO; Pinto Junior EP; Kendall C; Kerr LRFS
    Rev Bras Epidemiol; 2024; 27():e240012. PubMed ID: 38511822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNAD COVID-19: A powerful new tool for Public Health Surveillance in Brazil.
    Penna GO; Silva JAAD; Neto JC; Temporão JG; Pinto LF
    Cien Saude Colet; 2020 Sep; 25(9):3567-3571. PubMed ID: 32876259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian approach to improving spatial estimates of prevalence of COVID-19 after accounting for misclassification bias in surveillance data in Philadelphia, PA.
    Goldstein ND; Wheeler DC; Gustafson P; Burstyn I
    Spat Spatiotemporal Epidemiol; 2021 Feb; 36():100401. PubMed ID: 33509436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.